ECCO 2025

Novelties and Future Prospects in IBD

Antibody responses predict IBD onset 10 years before diagnosis

Presented By

Dr Arno Bourgonje, University Medical Center Groningen, the Netherlands

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:48

Therapeutic antibody clearance reliable predictor for endoscopic outcomes in CD

Presented By

Dr Erwin Dreesen, KU Leuven, Belgium

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:46

Higher neoplasia detection rate with virtual chromoendoscopy in real-world IBD study

Presented By

Dr Chandni Radia, King’s College London, UK

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:44

Reducing the carbon footprint of IBD care

Presented By

Dr Marjolijn Duijvestein, Radboud University Medical Center, the Netherlands

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:43

Emerging Treatment Options in IBD

TL1A-LTB axis induces perianal fistulising disease-associated changes in CD

Presented By

Dr Victoria Gudino, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Spain

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:31

Emulsifier-restrictive diet effective in alleviating symptoms in CD

Presented By

Dr Aaron Bancil, King’s College London, UK

Trial

ADDapt

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:26

Could stem cell transplantation be a fruitful solution for refractory CD?

Presented By

Dr Louis Cohen, Icahn School of Medicine at Mount Sinai, NY, USA

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:24

First IL-7 inhibitor for UC shows its potential

Presented By

Dr Arnaud Bourreille, CHU Nantes, France

Trial

Phase 2, CoTikiS

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:03

Novel TL1A inhibitor achieves high rates at stringent endpoints in UC

Presented By

Prof. Vipul Jairath, Western University, Canada

Trial

Phase 2, TUSCANY-2

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:57

Positive results for TL1A inhibitor duvakitug in CD

Presented By

Prof. Vipul Jairath, Western University, Canada

Trial

Phase 2, RELIEVE UCCD

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:52

New Data from Established Agents

Improving efficacy with longer mirikizumab treatment in CD

Presented By

Prof. Séverine Vermeire, KU Leuven, Belgium

Trial

Phase 3, VIVID-2

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:39

Long-term upadacitinib data reassuring for patients with UC

Presented By

Prof. Remo Panaccione, University of Calgary, Canada

Trial

Phase 3, U-ACTIVATE

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:37

EFFICACI: Infliximab or vedolizumab after TNF failure in UC?

Presented By

Prof. Guillaume Bouguen, CHU Rennes, France

Trial

EFFICACI

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:34

Latest data for subcutaneous guselkumab in CD and UC

Presented By

Prof. Ailsa Hart, London North-West University, UK; Prof. Laurent Peyrin-Biroulet, University of Lorraine, France

Trial

Phase 3, GRAVITI, ASTRO

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:31

Long-term use of etrasimod in UC safe and well-tolerated

Presented By

Prof. Séverine Vermeire, KU Leuven, Belgium

Trial

OASIS, ELEVATE, ES101002

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:22

Sustained efficacy and stable safety profile for risankizumab in UC

Presented By

Prof. Raja Atreya, Friedrich-Alexander University, Germany

Trial

Phase 3, COMMAND

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:08

VEDOKIDS: Long-term outcomes of vedolizumab in paediatric IBD

Presented By

Dr Ohad Atia, Shaare Zedek Medical Centre, Israel

Trial

VEDOKIDS

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:56

More News from ECCO 2025

PREdiCCT: Role of psychosocial factors in IBD flares unravelled

Presented By

Dr Lauranne Derikx, Erasmus MC, the Netherlands

Trial

PREdiCCT

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:49

Kono-S or side-to-side anastomosis for resection in Crohn’s terminal ileitis?

Presented By

Dr Koianka Trencheva, Cornell University, NY, USA

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:47

Identifying patients at high risk for chronic pouchitis

Presented By

Dr Edward Barnes, University of North Carolina at Chapel Hill, NC, USA

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:34

ECCO consensus on diet and nutrition in IBD

Presented By

Dr Richard Hansen, University of Dundee, UK; Dr Vaios Svolos, University of Thessaly, Greece

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:20

ECCO Topical Review: pouch-related disorders

Presented By

Dr Maia Kayal, Icahn School of Medicine at Mount Sinai, NY, USA

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:18